The results revealed that GPx2 expression impacted kynurenines (KYNU)-mediated metabolism, in addition to the involvement of the reactive oxygen species (ROS)-mediated KYNU-kyn-AhR signaling pathway in gastric cancer progression and metastasis following GPx2 knockdown. The gene discussed is AHR; the disease is gastric cancer.